The HEALEY ALS Platform Trial

Summary

The purpose of the HEALEY ALS Platform Trial is to evaluate the safety and effectiveness of multiple treatments for amyotrophic lateral sclerosis (ALS). A regimen is a specific course of treatment, each with a different study drug. Multiple regimens may be active at the same time within this platform trial. Participants will be randomly assigned to a regimen (one treatment). Within a regimen, participants will have a 3 in 4 chance of being assigned to the active drug group and a 1 in 4 chance of being assigned to the placebo (inactive substance) group. Researchers aim to determine whether these treatments have an effect on ALS and can be safely used without causing excessive side effects.


Inclusion Criteria

The HEALEY ALS Platform Trial


Study Location(s)

Beverly

More about this Clinical Trial

Full Title

The Healey ALS Platform Trial

Details
Disease Type/Condition

Amyotrophic lateral sclerosis (ALS)

Principal Investigator

Lewis, Richard

Age Group

Adult

Phase

N/A

IRB Number

STUDY00000445

ClinicalTrials.gov ID

NCT04297683

Key Eligibility
ClinicalTrials.gov

Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?

Details
Disease Type/Condition

Amyotrophic lateral sclerosis (ALS)

Principal Investigator

Lewis, Richard

Age Group

Adult

Phase

N/A

IRB Number

HEALEY-ALS-PLATFORM-TRIAL

ClinicalTrials.gov ID

NCT04297683

Key Eligibility
ClinicalTrials.gov

Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?